Correction to: Prognostic value of total metabolic tumour volume and therapy-response assessment by [
18
F]FDG PET/CT in patients with metastatic melanoma treated with BRAF/MEK inhibitors
Eur Radiol
.
2022 Aug;32(8):5783.
doi: 10.1007/s00330-022-08672-z.
Authors
Alessio Annovazzi
1
,
Virginia Ferraresi
2
3
,
Sandra Rea
4
,
Michelangelo Russillo
2
,
Davide Renna
2
,
Silvia Carpano
5
,
Rosa Sciuto
4
Affiliations
1
Nuclear Medicine Unit, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy. alessio.annovazzi@ifo.gov.it.
2
First Division of Medical Oncology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
3
Sarcomas and Rare Tumors Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
4
Nuclear Medicine Unit, IRCCS - Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy.
5
Second Division of Medical Oncology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
PMID:
35262771
DOI:
10.1007/s00330-022-08672-z
No abstract available
Publication types
Published Erratum